AVISE SLE Prognostic

The Specialized SLE Prognostic Test for Rheumatologists

AVISE® SLE Prognostic is a 10-marker panel developed to help assess a patient’s potential risk for Thrombosis, Cardiovascular events, Lupus Nephritis and Neuropsychiatric Lupus. The test includes the following assays:

Clinical Utility

AVISE SLE Prognostic Test Report

AVISE SLE Prognostic Test Report
Sample Test Report

Peer reviewed articles:


Akhter E, et al. Anti-C1q antibodies have higher correlation with fl ares of lupus nephritis than other serum markers. Lupus. 2011.  

Orbai A-M, et al. Anti-C1q Antibodies in Systemic Lupus Erythematosu. Lupus. 2015. 


Akhter E, et al. Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus Erythematosus. Journal of Rheumatism. 2013 

View Complete References

To learn more about AVISE testing please click the link below.

Learn More